ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

N Concin, X Matias-Guiu, I Vergote, D Cibula… - International Journal of …, 2021 - ijgc.bmj.com
A European consensus conference on endometrial carcinoma was held in 2014 to produce
multi-disciplinary evidence-based guidelines on selected questions. Given the large body of …

Pros and cons of vaginal brachytherapy after external beam radiation therapy in endometrial cancer

D Mitra, AH Klopp, AN Viswanathan - Gynecologic oncology, 2016 - Elsevier
A large number of studies have looked at the role of radiation therapy in the treatment of
endometrial cancer. One particular radiation strategy in common practice is the use of …

Adjuvant therapy of uterine clear cell carcinoma: a review

Y Xu, RK Hanna, MA Elshaikh - Archives of gynecology and obstetrics, 2016 - Springer
Purpose Uterine clear-cell carcinoma (UCCC) is a rare subset of type II endometrial
carcinoma with a poor prognosis relative to the most common type of endometrioid …

Factors prognostic of survival in advanced-stage uterine serous carcinoma

LL Holman, N Pal, DA Iglesias, PT Soliman… - Gynecologic …, 2017 - Elsevier
Objectives The study objective was to analyze the impact of prognostic factors, including
treatment modality, on outcome in patients with advanced-stage uterine serous carcinoma …

Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma

M Xiang, DP English, EA Kidd - Gynecologic Oncology, 2019 - Elsevier
Objectives To determine which patients with locoregionally advanced endometrial cancer
may benefit from pelvic external beam radiotherapy (EBRT) in addition to chemotherapy …

Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group …

JR Chen, TC Chang, HC Fu, HY Lau, IH Chen, YM Ke… - Medicine, 2016 - journals.lww.com
In the management of patients with advanced-stage pure endometrioid-type endometrial
cancer (E-EC), such as positive lymph nodes (stage III) or stage IV, treatment options are …

Sentinel lymph node mapping reduces practice pattern variations in surgical staging for endometrial adenocarcinoma: a before and after study

CY Liu, KM Elias, BE Howitt, LJ Lee, CM Feltmate - Gynecologic Oncology, 2017 - Elsevier
Objective To examine the effects of universal sentinel lymph node mapping on the use of
nodal staging in endometrial adenocarcinoma. Methods Two approaches to laparoscopic …

The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) …

NM Spirtos, D Enserro, HD Homesley, SK Gibbons… - Gynecologic …, 2019 - Elsevier
Objectives To determine if the addition of paclitaxel (P) to cisplatin and doxorubicin (CD)
following surgical debulking and volume-directed radiation therapy improved long-term …

Impact of adjuvant modalities on survival in patients with advanced stage endometrial carcinoma: a retrospective analysis from a tertiary medical center

YJ Tai, HC Hsu, YC Chiang, YL Chen… - International Journal of …, 2019 - mdpi.com
Adjuvant treatment in advanced-stage (stages III/IV) endometrial carcinomas in terms of
tumor grades has not yet been explored. We retrospectively analyzed 194 patients with …

Treatment outcomes of endometrial cancer patients with paraaortic lymph node metastasis: a multi-institutional analysis

C Onal, BA Yildirim, SY Sari, G Yavas… - International Journal of …, 2019 - ijgc.bmj.com
Objective To analyze the prognostic factors and treatment outcomes in endometrial cancer
patients with paraaortic lymph node metastasis. Methods Data from four centers were …